No Summary
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths
Sources
Paywall and unreadable sources
-
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths
WSJ
-
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
Fierce Biotech
-
Novartis pauses immunology, neuro CAR-T studies after three patient deaths
FirstWord Pharma
-
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Endpoints News
-
Novartis pauses trials of experimental cell therapy after three deaths
Reuters